Skip to main content
    L

    LivaNova PLC (LIVN)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $92.44
    +1.12 (+1.23%)

    Market Cap: $5.03B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    LivaNova PLC (LIVN) Financials: Revenue, Profit and Cash Flow

    Updated Nov 4, 2026. Financial statements from company filings, amounts in US dollars.

    LivaNova reported revenue of $1.39B for the fiscal year ended Dec 31, 2025, up 10.7% from the year before. That year, net income was -$242.50M with a net margin of -17.5%, operating cash flow was $254.30M and free cash flow was $173.20M. The quarter ended Sep 30, 2026 had revenue of $393.10M and net income of $34.30M.

    Revenue and Margins

    The operating margin was 14.4% in the fiscal year ended Dec 2025, the highest of the 10 years shown. Over the 9 years to Dec 2025, revenue grew from $1.21B, a compound annual rate of 1.6%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$1.39B+10.7%67.7%14.4%-17.5%
    Dec 2024$1.25B+8.7%69.5%10.3%5.0%
    Dec 2023$1.15B+12.9%66.9%-5.9%1.5%
    Dec 2022$1.02B-1.3%69.2%-7.5%-8.4%
    Dec 2021$1.04B+10.8%68.2%-0.1%-13.1%
    Dec 2020$934.24M-13.8%63.7%-29.3%-37.3%
    Dec 2019$1.08B-2.1%66.8%-15.8%-14.5%
    Dec 2018$1.11B+9.4%66.4%-22.4%-17.1%
    Dec 2017$1.01B-16.6%64.4%9.5%-2.5%
    Dec 2016$1.21BN/A58.0%-2.3%-5.2%
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the company posted a net loss after a profit the year before. In the quarter ended Sep 2026, net income rose 28.0% from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue$1.39B$1.25B$1.15B$1.02B$1.04B$934.24M$1.08B$1.11B$1.01B$1.21B
    Cost of revenue$448.20M$382.56M$382.30M$314.58M$329.37M$339.48M$360.37M$372.50M$360.70M$509.50M
    Gross profit$939.90M$870.87M$771.25M$707.23M$705.99M$594.76M$723.80M$734.50M$651.60M$704.40M
    Research and development$185.80M$182.51M$193.82M$155.81M$183.41M$152.90M$197.15M$146.00M$109.70M$122.50M
    Operating income$199.40M$129.05M-$68.50M-$76.75M-$784.00K-$273.90M-$171.55M-$248.10M$95.70M-$27.60M
    Net income-$242.50M$63.23M$17.55M-$86.25M-$135.82M-$348.82M-$157.64M-$189.40M-$25.10M-$62.80M
    EBITDAN/A$202.52M$38.48M$30.90MN/A$20.33M$131.48M-$167.68M$199.13M$121.19M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$393.10M$390.60M$362.26M$360.86M$357.80M$352.52M$316.86M$321.83M$318.12M$318.57M$294.91M$310.13M
    Gross profit$265.00M$273.70M$244.85M$239.78M$244.90M$238.99M$220.78M$219.35M$225.26M$214.88M$207.39M$190.17M
    Operating income$28.40M$49.50M$52.19M$42.62M$54.00M$54.18M$48.62M$37.02M$35.62M$40.17M$16.25M-$87.99M
    Net income$34.30M$108.60M$22.30M$30.88M$26.80M$27.16M-$327.32M$55.89M$32.95M$16.33M-$41.94M$16.34M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, cash and equivalents exceeded total debt of $376.69M by $258.92M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$2.61B$2.51B$2.43B$2.29B$2.20B$2.40B$2.41B$2.55B$2.50B$2.34B
    Current assets$1.10B$1.13B$988.16M$886.14M$679.18M$708.04M$549.44M$533.30M$869.90M$620.10M
    Cash and equivalents$635.60M$428.86M$266.50M$214.17M$207.99M$252.83M$61.14M$47.20M$93.60M$39.80M
    Total liabilities$1.41B$1.19B$1.15B$1.09B$906.31M$1.29B$1.03B$1.05B$688.60M$635.70M
    Short-term debt$31.50M$87.04M$26.47M$32.81M$240.93M$24.62M$88.51M$28.80M$84.03M$47.70M
    Long-term debt$345.19M$549.62M$568.54M$518.07M$9.80M$642.30M$260.33M$139.54M$61.96M$75.22M
    Shareholder equity$1.20B$1.32B$1.28B$1.21B$1.29B$1.11B$1.38B$1.50B$1.82B$1.71B
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$2.71B$2.64B$2.52B$2.61B$2.56B$2.51B$2.56B$2.51B$2.52B$2.45B$2.46B$2.43B
    Total liabilities$1.34B$1.32B$1.30B$1.41B$1.40B$1.38B$1.52B$1.19B$1.21B$1.21B$1.24B$1.15B
    Cash and equivalents$563.50M$516.62M$539.70M$635.60M$646.08M$593.64M$738.44M$428.86M$346.37M$329.24M$309.19M$266.50M
    Shareholder equity$1.37B$1.33B$1.21B$1.20B$1.16B$1.12B$1.03B$1.32B$1.31B$1.24B$1.22B$1.28B
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Dec 2025, free cash flow was 68.1% of operating cash flow.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow$254.30M$183.04M$74.91M$69.90M$102.54M-$79.40M-$91.14M$120.50M$91.30M$90.20M
    Capital expenditures$81.10M$47.11M$34.98M$26.50M$25.48M$35.00M$24.69M$38.00M$34.10M$37.20M
    Free cash flow$173.20M$135.93M$39.93M$43.40M$77.07M-$114.40M-$115.83M$82.50M$57.20M$53.00M
    Dividends paidN/AN/AN/AN/AN/AN/A$4.84MN/A$0$0
    Investing cash flow-$72.90M-$48.16M-$40.33M-$38.40M$36.90M-$41.80M-$41.29M-$120.60M-$52.90M-$38.20M
    Financing cash flow-$285.70M$18.55M$21.48M$280.10M-$181.48M$310.80M$146.58M-$42.30M$11.30M-$124.30M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow$73.60M$66.59M$15.22M$82.40M$85.06M$62.92M$23.97M$78.71M$50.99M$43.36M$9.98M$53.96M
    Capital expenditures$30.80M$31.55M$14.29M$32.20M$22.88M$15.15M$10.79M$10.41M$18.15M$12.16M$6.40M$12.92M
    Free cash flow$42.80M$35.04M$926.00K$50.20M$62.18M$47.77M$13.18M$68.30M$32.85M$31.20M$3.58M$41.04M
    Last 12 quarters

    Frequently Asked Questions About LIVN

    What is LivaNova's annual revenue?

    LivaNova reported revenue of $1.39B for the fiscal year ended Dec 31, 2025.

    How fast is LivaNova's revenue growing?

    Revenue was up 10.7% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 10.8%.

    Is LivaNova profitable?

    No. LivaNova reported net income of -$242.50M for the fiscal year ended Dec 31, 2025, with a net margin of -17.5%.

    How much free cash flow does LIVN generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of $254.30M minus capital expenditures of $81.10M produced free cash flow of $173.20M.

    How much debt does LivaNova have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $345.19M, short-term debt of $31.50M and cash and equivalents of $635.60M.